by stemcellclub | Oct 14, 2026 | Stem Cell Injections, Stem Cell Therapy
Research Spotlight · Clinical Trial A Korean stem cell product that has been sold since 2012 just started its U.S. pivotal trial. It is a surgery, not a shot. It uses cord blood cells, not cord tissue. And it is not approved here. Here is what CARTISTEM is, what the...
by stemcellclub | Oct 12, 2026 | Stem Cell Therapy
Research Spotlight · FDA Approval In December 2024 the FDA approved the first mesenchymal stromal cell therapy in the United States. That is a real milestone. It is also narrower, and more specific, than most headlines make it sound. Here is what Ryoncil actually is,...
by stemcellclub | Oct 9, 2026 | Stem Cell Therapy
Research Spotlight · Type 1 Diabetes In an early trial, 10 of 12 people with type 1 diabetes were off insulin a year after one infusion of lab-grown islet cells. That is a real result. So are the trade-offs. Here is the whole story, in plain English. By The Stem Cell...
by stemcellclub | Oct 7, 2026 | Stem Cell Injections, Stem Cell Therapy
Research Spotlight · Knee Osteoarthritis One new trial says umbilical cord stem cell injections beat a standard knee shot. Another says fat-derived stem cells did no better than salt water. Then the American College of Rheumatology weighed in. Here is what all three...
by stemcellclub | Oct 5, 2026 | Stem Cell Therapy
Research Spotlight · Regenerative Medicine Japan Approves the World’s First iPS Cell Therapies: What It Means (and What It Doesn’t) In March 2026, Japan granted conditional, time-limited approval to Amchepry for Parkinson’s and RiHEART for severe...